BACKGROUND: Case-control studies from the early 2000s demonstrated that human papillomavirus-related oropharyngeal cancer (HPV-OPC) is a distinct entity associated with number of oral sex partners. Using contemporary data, we investigated novel risk factors (sexual debut behaviors, exposure intensity, and relationship dynamics) and serological markers on odds of HPV-OPC. METHODS: HPV-OPC patients and frequency-matched controls were enrolled in a multicenter study from 2013 to 2018. Participants completed a behavioral survey. Characteristics were compared using a chi-square test for categorical variables and a t test for continuous variables. Adjusted odds ratios (aOR) were calculated using logistic regression. RESULTS: A total of 163 HPV-OPC patients and 345 controls were included. Lifetime number of oral sex partners was associated with significantly increased odds of HPV-OPC (>10 partners: odds ratio [OR], 4.3 [95% CI, 2.8-6.7]). After adjustment for number of oral sex partners and smoking, younger age at first oral sex (<18 vs >20 years: aOR, 1.8 [95% CI, 1.1-3.2]) and oral sex intensity (>5 sex-years: aOR, 2.8 [95% CI, 1.1-7.5]) remained associated with significantly increased odds of HPV-OPC. Type of sexual partner such as older partners when a case was younger (OR, 1.7 [95% CI, 1.1-2.6]) or having a partner who had extramarital sex (OR, 1.6 [95% CI, 1.1-2.4]) was associated with HPV-OPC. Seropositivity for antibodies to HPV16 E6 (OR, 286 [95% CI, 122-670]) and any HPV16 E protein (E1, E2, E6, E7; OR, 163 [95% CI, 70-378]) was associated with increased odds of HPV-OPC. CONCLUSION: Number of oral sex partners remains a strong risk factor for HPV-OPC; however, timing and intensity of oral sex are novel independent risk factors. These behaviors suggest additional nuances of how and why some individuals develop HPV-OPC.
BACKGROUND: Case-control studies from the early 2000s demonstrated that human papillomavirus-related oropharyngeal cancer (HPV-OPC) is a distinct entity associated with number of oral sex partners. Using contemporary data, we investigated novel risk factors (sexual debut behaviors, exposure intensity, and relationship dynamics) and serological markers on odds of HPV-OPC. METHODS: HPV-OPC patients and frequency-matched controls were enrolled in a multicenter study from 2013 to 2018. Participants completed a behavioral survey. Characteristics were compared using a chi-square test for categorical variables and a t test for continuous variables. Adjusted odds ratios (aOR) were calculated using logistic regression. RESULTS: A total of 163 HPV-OPC patients and 345 controls were included. Lifetime number of oral sex partners was associated with significantly increased odds of HPV-OPC (>10 partners: odds ratio [OR], 4.3 [95% CI, 2.8-6.7]). After adjustment for number of oral sex partners and smoking, younger age at first oral sex (<18 vs >20 years: aOR, 1.8 [95% CI, 1.1-3.2]) and oral sex intensity (>5 sex-years: aOR, 2.8 [95% CI, 1.1-7.5]) remained associated with significantly increased odds of HPV-OPC. Type of sexual partner such as older partners when a case was younger (OR, 1.7 [95% CI, 1.1-2.6]) or having a partner who had extramarital sex (OR, 1.6 [95% CI, 1.1-2.4]) was associated with HPV-OPC. Seropositivity for antibodies to HPV16 E6 (OR, 286 [95% CI, 122-670]) and any HPV16 E protein (E1, E2, E6, E7; OR, 163 [95% CI, 70-378]) was associated with increased odds of HPV-OPC. CONCLUSION: Number of oral sex partners remains a strong risk factor for HPV-OPC; however, timing and intensity of oral sex are novel independent risk factors. These behaviors suggest additional nuances of how and why some individuals develop HPV-OPC.
Authors: Krystle A Lang Kuhs; Devasena Anantharaman; Tim Waterboer; Mattias Johansson; Paul Brennan; Angelika Michel; Martina Willhauck-Fleckenstein; Mark P Purdue; Ivana Holcátová; Wolfgang Ahrens; Pagona Lagiou; Jerry Polesel; Lorenzo Simonato; Franco Merletti; Claire M Healy; Kristina Kjaerheim; David I Conway; Tatiana V Macfarlane; Peter Thomson; Xavier Castellsagué; Ariana Znaor; Amanda Black; Wen-Yi Huang; Vittorio Krogh; Antonia Trichopoulou; H B As Bueno-de-Mesquita; Françoise Clavel-Chapelon; Elisabete Weiderpass; Johanna Ekström; Elio Riboli; Anne Tjønneland; María-José Sánchez; Ruth C Travis; Allan Hildesheim; Michael Pawlita; Aimée R Kreimer Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-01-26 Impact factor: 4.254
Authors: Julia E Heck; Julien Berthiller; Salvatore Vaccarella; Deborah M Winn; Elaine M Smith; Oxana Shan'gina; Stephen M Schwartz; Mark P Purdue; Agnieszka Pilarska; Jose Eluf-Neto; Ana Menezes; Michael D McClean; Elena Matos; Sergio Koifman; Karl T Kelsey; Rolando Herrero; Richard B Hayes; Silvia Franceschi; Victor Wünsch-Filho; Leticia Fernández; Alexander W Daudt; Maria Paula Curado; Chu Chen; Xavier Castellsagué; Gilles Ferro; Paul Brennan; Paolo Boffetta; Mia Hashibe Journal: Int J Epidemiol Date: 2009-12-18 Impact factor: 7.196
Authors: Mia Hashibe; Hal Morgenstern; Yan Cui; Donald P Tashkin; Zuo-Feng Zhang; Wendy Cozen; Thomas M Mack; Sander Greenland Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-10 Impact factor: 4.254
Authors: Yuehan Zhang; Tim Waterboer; Robert I Haddad; Brett A Miles; Alicia Wentz; Neil D Gross; Carole Fakhry; Harry Quon; Jochen H Lorch; Christine G Gourin; Daniel Clayburgh; Krzysztof J Misiukiewicz; Jeremy D Richmon; Peter E Andersen; Marshall R Posner; Gypsyamber D'Souza Journal: Oral Oncol Date: 2017-02-15 Impact factor: 5.337
Authors: Claudie Laprise; Sreenath Arekunnath Madathil; Nicolas F Schlecht; Geneviève Castonguay; Denis Soulières; Phuc Felix Nguyen-Tan; Paul Allison; François Coutlée; Michael Hier; Marie-Claude Rousseau; Eduardo L Franco; Belinda Nicolau Journal: Head Neck Date: 2019-01-03 Impact factor: 3.147
Authors: Julien Berthiller; Yuan-Chin Amy Lee; Paolo Boffetta; Qingyi Wei; Erich M Sturgis; Sander Greenland; Hal Morgenstern; Zuo-Feng Zhang; Philip Lazarus; Joshua Muscat; Chu Chen; Stephen M Schwartz; José Eluf Neto; Victor Wünsch Filho; Sergio Koifman; Maria Paula Curado; Elena Matos; Leticia Fernandez; Ana Menezes; Alexander W Daudt; Gilles Ferro; Paul Brennan; Mia Hashibe Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-05 Impact factor: 4.254
Authors: Jordi Rubió-Casadevall; Elna Ciurana; Montserrat Puigdemont; Arantza Sanvisens; Jordi Marruecos; Josefina Miró; Antoni Urban; Rosa-Lisset Palhua; Ferran Martín-Romero; Maria Rosa Ortiz-Duran; Rafael Marcos-Gragera Journal: Int J Environ Res Public Health Date: 2022-04-15 Impact factor: 4.614
Authors: Nicholas Scott-Wittenborn; Gypsyamber D'Souza; Sakshi Tewari; Lisa Rooper; Tanya Troy; Virginia Drake; Elaine O Bigelow; Melina J Windon; William R Ryan; Patrick K Ha; Ana P Kiess; Brett Miles; William H Westra; Wojciech K Mydlarz; David W Eisele; Carole Fakhry Journal: Cancer Date: 2022-02-08 Impact factor: 6.921
Authors: Imran O Morhason-Bello; Kirstin Mitchell; Ayodele S Jegede; Isaac F Adewole; Suzanna C Francis; Deborah Watson-Jones Journal: Arch Sex Behav Date: 2022-09-19
Authors: Virginia Drake; Elaine Bigelow; Carole Fakhry; Melina Windon; Lisa M Rooper; Patrick Ha; Brett Miles; Christine Gourin; Rajarsi Mandal; Wojciech Mydlarz; Nyall London; Peter S Vosler; Siddhartha Yavvari; Tanya Troy; Tim Waterboer; David W Eisele; Gypsyamber D'Souza Journal: Oral Oncol Date: 2021-07-22 Impact factor: 5.972